Get In Touch

This site uses cookies and similar technology to function properly and to provide the services present on it, analytical cookies (our own and third party) to understand and improve users’ browsing experience, and profiling cookies (our own and third party) to serve you advertisements in line with preferences displayed while browsing online. For further information, see our Cookie Policy . To refuse consent for some or all cookies, click here. By clicking “I agree”, you consent to the use of the aforementioned cookies.

I agree

Hodge Jones & Allen becomes founding partner of British Lung Foundation patron scheme

Law firm Hodge Jones & Allen has joined forces with the British Lung Foundation (BLF) to provide funding for research into mesothelioma and to work with them to provide guidance and support to those diagnosed with this deadly disease.

BLF is the leading charity funding research into mesothelioma and lung disease and they continue to need support for their groundbreaking research. The patron scheme is designed to raise awareness of those leading the challenge to find a cure for mesothelioma.

Commenting on the new partnership, Isobel Lovett, partner and Head of Asbestos and Mesothelioma Compensation department at Hodge Jones & Allen, said: “The UK has the worst published mortality rates in the world for mesothelioma, due to high asbestos use by our industries and businesses in the past. Becoming a BLF patron gives us the opportunity to provide funds for their much needed research and to work closely with Dr Penny Woods and her team. We are committed to helping them make a real difference in reducing the numbers of deaths in this country.”

“The BLF has produced groundbreaking studies over the last 10 years, and Hodge Jones & Allen want to play their part in helping to bring about more significant improvements, particularly around earlier diagnosis and improved life expectancy.”

Dr Penny Woods, Chief Executive of the British Lung Foundation, said: “We are very pleased to have Hodge Jones & Allen as our founding gold patron; we rely on funding to help us continue our research into lung disease. Mesothelioma is a relatively rare cancer, but it is deadly and kills around 2,500 people a year, that’s why we need to step up research to find a cure or treatment to halt the progression of this disease.”